Cargando…

Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors

Detalles Bibliográficos
Autores principales:	Wu, Qiuji, Chu, Qian, Zhang, Hongyan, Yang, Bin, He, Xudong, Zhong, Yahua, Yuan, Xianglin, Chua, Melvin L.K., Xie, Conghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405291/ https://www.ncbi.nlm.nih.gov/pubmed/32666636 http://dx.doi.org/10.1002/cac2.12077

Ejemplares similares

Outcomes of novel coronavirus disease 2019 (COVID‐19) infection in 107 patients with cancer from Wuhan, China
por: Zhang, Hongyan, et al.
Publicado: (2020)

The Management of Patients With Lung Cancer During the Outbreak of Coronavirus Disease 2019
por: Ouyang, Wen, et al.
Publicado: (2020)

Outcomes in Radiotherapy-Treated Patients With Cancer During the COVID-19 Outbreak in Wuhan, China
por: Xie, Conghua, et al.
Publicado: (2020)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation
por: Li, Li, et al.
Publicado: (2018)

Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020)

Dosimetric Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitors
por: Bi, Jianping, et al.
Publicado: (2022)

Follow-Up and Management of Patients With Head and Neck Cancer During the 2019 Novel Coronavirus (SARS-CoV-2) Disease Pandemic
por: Chua, Melvin L.K., et al.
Publicado: (2020)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

Indications for and contraindications of immune checkpoint inhibitors in cancer patients with coronavirus disease 2019 vaccination
por: Luo, Bangyu, et al.
Publicado: (2021)

A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group
por: Al‐Shamsi, Humaid O., et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on head and neck cancer patients
por: Chen, Gaili, et al.
Publicado: (2020)

Differential expression of COL4A3 and collagen in upward and downward progressing types of nasopharyngeal carcinoma
por: Yang, Xiting, et al.
Publicado: (2021)

Identification of Two m6A Readers YTHDF1 and IGF2BP2 as Immune Biomarkers in Head and Neck Squamous Cell Carcinoma
por: Li, Shaojie, et al.
Publicado: (2022)

A retrospective analysis on metastatic rate of the internal mammary lymph node and its clinical significance in adjuvant radiotherapy of breast cancer patients
por: Li, Li, et al.
Publicado: (2020)

Optimization of supraclavicular lymph node clinical target volume delineation in high-risk breast cancer: a single center experience and recommendation
por: Li, Li, et al.
Publicado: (2023)

Bioanalytical Challenges due to Prior Checkpoint Inhibitor Exposure: Interference and Mitigation in Drug Concentration and Immunogenicity Assays
por: Dengler, Andrew F., et al.
Publicado: (2021)

Coronavirus Disease 2019 in Patients With Prior Ischemic Stroke
por: Nalleballe, Krishna, et al.
Publicado: (2020)

Consideration of Severe Coronavirus Disease 2019 As Viral Sepsis and Potential Use of Immune Checkpoint Inhibitors
por: Odabasi, Zekaver, et al.
Publicado: (2020)

Tumor kinetics prior to treatment correlate with response to checkpoint inhibitors
por: Cadena, Alexandra P, et al.
Publicado: (2015)

Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
por: Bylsma, Sophia, et al.
Publicado: (2022)

Prospects and feasibility of synergistic therapy with radiotherapy, immunotherapy, and DNA methyltransferase inhibitors in non-small cell lung cancer
por: Jie, Chen, et al.
Publicado: (2023)

Primary Adenoid Cystic Carcinoma of the Upper Anterior Mediastinum Mimicking a Thyroid Tumor: A Case Report and Review of Literature
por: Wu, Qiuji, et al.
Publicado: (2020)

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab
por: Wu, Qiuji, et al.
Publicado: (2021)

Safety of sequential immune checkpoint inhibitors after prior immune therapy
por: Awidi, Muhammad, et al.
Publicado: (2022)

Could the new coronavirus have infected humans prior November 2019?
por: Tichopád, Aleš, et al.
Publicado: (2021)

Characteristics of Postvaccination Coronavirus Disease 2019 Hospitalizations Prior to Booster Vaccines
por: Moffa, Matthew A, et al.
Publicado: (2022)

Prior and novel coronaviruses, Coronavirus Disease 2019 (COVID-19), and human reproduction: what is known?
por: Segars, James, et al.
Publicado: (2020)

Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study
por: Nikita, Nikita, et al.
Publicado: (2022)

Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy
por: Plesca, Ioana, et al.
Publicado: (2020)

Surgery as an alternative to radiotherapy in early‐stage nasopharyngeal carcinoma: innovation at the expense of uncertainty
por: Huang, Luo, et al.
Publicado: (2020)

Treatment and Outcome of a Patient With Lung Cancer Infected With Severe Acute Respiratory Syndrome Coronavirus-2
por: Zhang, Hongyan, et al.
Publicado: (2020)

Ipilimumab and nivolumab/pembrolizumab in advanced hepatocellular carcinoma refractory to prior immune checkpoint inhibitors
por: Wong, Jeffrey Sum Lung, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
por: Katariya, Nitin N., et al.
Publicado: (2022)

Sleep quality and mental health of medical workers during the coronavirus disease 2019 pandemic
por: Zheng, Yahua, et al.
Publicado: (2021)

Comparison of Definitive Radiotherapy-Based Treatment and Surgical-Based Treatment for Locally Advanced Head and Neck Soft Tissue Sarcoma
por: Wu, Qiuji, et al.
Publicado: (2023)

Membranous Nephropathy After Exposure to Immune Checkpoint Inhibitors
por: Benyahia, Rayane, et al.
Publicado: (2023)

Adjuvant treatment following radical cystectomy for muscle-invasive urothelial carcinoma and variant histologies: Is there a role for radiotherapy?
por: Chua, Kevin LM, et al.
Publicado: (2017)

SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
por: Yu, Jing, et al.
Publicado: (2020)

Systemic immune parameters after prior radiation therapy in patients receiving immune checkpoint inhibitors
por: Mundra, Vatsala, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1nl9piu907ctbt47jluibj3p1m